i&i Prague and ÚHKT Join Forces to Bring an Innovative Sample Preparation Technology to Market

Prague, March 18, 2025 – i&i Prague, a leading Czech biotech incubator, has announced a collaboration with the Institute of Hematology and Blood Transfusion (ÚHKT) to commercialize an innovative liquid microextraction technology. Developed by Dr. Matyáš Krijt and Associate Professor Daniel Vyoral, this technology enables fast and efficient separation of two immiscible liquids without the loss of analytes, even in a parallel setup suitable for robotics and automation. The further development and production of the final commercial product will be handled by Medirekt Partner.

​

By combining cutting-edge academic research, expert technology transfer, and industrial know-how, this project paves the way for successful commercialization. It serves as another example of how collaboration between the public and private sectors can bring scientific discoveries closer to real-world applications and improve the efficiency of laboratory processes.

​

Faster, More Cost-Effective, and Eco-Friendly Liquid Separation

“The new patented technology represents a major breakthrough in sample preparation for analytical laboratories. Unlike traditional methods, it utilizes a unique principle based on a hydrophobic or hydrophilic surface treatment of a capillary opening. The absence of a frit or membrane prevents analyte retention and enables parallel processing of samples using liquid microseparation techniques,” explain the technology's inventors, Matyáš Krijt and Daniel Vyoral.

 

A Technology with Significant Market Potential

The Institute of Hematology and Blood Transfusion plays a crucial role in this project, actively supporting the commercialization of the technology. “ÚHKT recognizes this technology, developed within the TAČR Gama project, as a significant innovation with real market potential. It can be used in virtually any laboratory involved in analytical sample preparation, offering a faster, more precise and cost-efficient alternative to current technologies,” says Petr Lesný, Head of Technology Transfer at ÚHKT.

 

i&i Prague as a Key Accelerator of Technology Transfer

i&i Prague specializes in supporting innovations in biotechnology, including the development of laboratory diagnostics and new therapeutics. “We see great potential in this technology and are excited to help bring another innovation from a Czech research institution to life,” says Jiří Moos, CEO of i&i Prague. “We have acquired the intellectual property rights from ÚHKT, and together with our project partners, we believe this innovation can be transformed into a successful commercial product.”

 

Collaboration with Medirekt Partner for Market Entry

Industrial partnerships are essential for successfully bringing this technology to market. Medirekt Partner is responsible for product development, manufacturing, and ensuring that the final product meets customer needs. “The technology has successfully undergone laboratory testing and is now being refined for commercial use. We aim to create a product that meets the highest demands of analytical laboratories while offering a more economical (up to ten times more cost-effective) and environmentally friendly (up to a tenfold reduction in the volumes of solvents currently used) solution for sample preparation,” says Jiří Sopuch from Medirekt Partner.

​

Press Contacts

Martin Kovalčík – kovalcik@iniprague.com, +420 777 472 863
Jiří Sopuch – jiri.sopuch@medirektpartner.cz, +420 605 826 081